GlassScriptPhysician profile
Maria M Murphy
NPI 1750371662
$138,195.66
in general payments reported to CMS, 2019-2025
24 companies · $13K in 2025
The $13K reported for 2025 was more than what 94% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $9,947 · 2021: $7,126 · 2022: $21K · 2023: $24K · 2024: $27K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $52K · Travel and Lodging: $6,884 · Food and Beverage: $4,645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $52,300.00 |
| Travel and Lodging | $6,884.39 |
| Food and Beverage | $4,645.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $90,782.43 | 2019-2025 | Interstim, Signia, Gi Genius |
| Medtronic USA, INC. | $40,783.17 | 2019-2020 | |
| Intuitive Surgical, INC. | $3,910.93 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $350.36 | 2019-2024 | Trulance |
| Integra Lifesciences Corporation | $281.75 | 2020-2023 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Rti Surgical, INC | $238.03 | 2024-2025 | |
| Allergan, INC. | $225.95 | 2019-2021 | |
| Ethicon US, LLC | $222.85 | 2019-2021 | |
| Thd America, INC. | $221.49 | 2019-2025 | |
| Tela Bio, INC. | $207.22 | 2019-2022 | |
| Stryker Corporation | $186.17 | 2019-2024 | 1788 |
| Medical Device Business Services, INC. | $182.66 | 2023-2024 | Vistaseal |
| Convatec INC. | $138.37 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $114.29 | 2019-2025 | Entyvio |
| Kci USA, INC. | $108.99 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $45.15 | 2019 | |
| Cook Medical LLC | $35.20 | 2019 | |
| Organogenesis INC. | $34.89 | 2019 | |
| Braintree Laboratories, INC. | $31.38 | 2019-2024 | Suflave |
| Trevena, INC. | $23.28 | 2021 | |
| Baudax Bio INC. | $18.95 | 2020 | |
| Innovation Technologies INC | $18.00 | 2019 | |
| Ferring Pharmaceuticals INC. | $17.08 | 2022 | |
| Collegium Pharmaceutical, INC. | $17.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.